Mirum Pharmaceuticals (MIRM) Interest Coverage Ratio Growth (3y) (2022 - 2026)
Mirum Pharmaceuticals (MIRM) Interest Coverage Ratio Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Mirum Pharmaceuticals | 6.73 Bn | 6.34 Bn | 131.08 Mn | -232.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -232.42% |
| Dec 31, 2025 | 58.35% |
| Sep 30, 2025 | 26.04% |
| Jun 30, 2025 | 75.47% |
| Mar 31, 2025 | 63.70% |
| Dec 31, 2024 | 17.61% |
| Sep 30, 2024 | 77.83% |
| Jun 30, 2024 | 49.10% |
| Mar 31, 2024 | 76.75% |
| Dec 31, 2023 | -26.03% |
| Sep 30, 2023 | 30.41% |
| Jun 30, 2023 | -15.19% |
| Mar 31, 2023 | -2.83% |
| Dec 31, 2022 | -201.48% |
| Sep 30, 2022 | -100.88% |
| Jun 30, 2022 | -33.47% |